Publication | Open Access
Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial
194
Citations
20
References
2013
Year
National Institutes of Health, US Department of Defense.
| Year | Citations | |
|---|---|---|
Page 1
Page 1